Cargando…

Assessing inclusion of trans people in HIV national strategic plans: a review of 60 high HIV prevalence countries

INTRODUCTION: Trans people are disproportionately impacted by HIV yet have not been adequately prioritized in national HIV responses or policy documents. This review aims to understand the extent of meaningful inclusion of trans people in national strategic plans (NSPs) for HIV/AIDS as an essential...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherwood, Jennifer, Lankiewicz, Elise, Castellanos, Erika, O'Connor, Naomhán, Theron, Liesl, Restar, Arjee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582022/
https://www.ncbi.nlm.nih.gov/pubmed/34761871
http://dx.doi.org/10.1002/jia2.25837
_version_ 1784596896490192896
author Sherwood, Jennifer
Lankiewicz, Elise
Castellanos, Erika
O'Connor, Naomhán
Theron, Liesl
Restar, Arjee
author_facet Sherwood, Jennifer
Lankiewicz, Elise
Castellanos, Erika
O'Connor, Naomhán
Theron, Liesl
Restar, Arjee
author_sort Sherwood, Jennifer
collection PubMed
description INTRODUCTION: Trans people are disproportionately impacted by HIV yet have not been adequately prioritized in national HIV responses or policy documents. This review aims to understand the extent of meaningful inclusion of trans people in national strategic plans (NSPs) for HIV/AIDS as an essential step in ensuring that HIV policy aligns with epidemiologic data, and trans‐specific programming is funded, implemented and sustained. METHODS: HIV NSPs from 60 countries, across five global regions, were assessed for the level of inclusion of trans populations between January and March 2021. The most recently available NSP for each country, published after 2011, was obtained through publicly accessible online sources or through researcher networks. Data were manually extracted from NSPs using a framework of indicators focusing on trans inclusion in these five major sections of NSPs: (1) narratives; (2) epidemiological data; (3) monitoring and evaluation (M&E) indicators and targets; (4) activities; and (5) budgets. RESULTS AND DISCUSSION: Within all reviewed NSPs, 65.0% (39/60) mentioned trans people in at least one of the five key sections but only 8.3% (5/60) included trans people in all five key sections. Trans people were more commonly mentioned in the background/narratives of NSPs (61.7%, 37/60) but less commonly included NSP activities (38.3%, 23/60), in M&E indicators and targets (23.7%, 14/60), in epidemiological data (20.0% 12/60), and in NSP budgets (13.3%, 8/60). Countries in the Asia and Pacific region most frequently included trans people in all five key sections (38%, 5/13), while no countries in Eastern and Southern Africa included trans people in all NSP sections. CONCLUSIONS: This analysis finds substantial gaps in the inclusion of trans populations in NSPs globally. Results highlight the pressing need for states, technical partners, and international funders to engage with trans communities to improve trans‐inclusion in all key sections of NSPs. Trans inclusion in NSPs is an essential step towards reaching the populations most at risk of HIV and ultimately achieving country‐level epidemic control.
format Online
Article
Text
id pubmed-8582022
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85820222021-11-17 Assessing inclusion of trans people in HIV national strategic plans: a review of 60 high HIV prevalence countries Sherwood, Jennifer Lankiewicz, Elise Castellanos, Erika O'Connor, Naomhán Theron, Liesl Restar, Arjee J Int AIDS Soc Reviews INTRODUCTION: Trans people are disproportionately impacted by HIV yet have not been adequately prioritized in national HIV responses or policy documents. This review aims to understand the extent of meaningful inclusion of trans people in national strategic plans (NSPs) for HIV/AIDS as an essential step in ensuring that HIV policy aligns with epidemiologic data, and trans‐specific programming is funded, implemented and sustained. METHODS: HIV NSPs from 60 countries, across five global regions, were assessed for the level of inclusion of trans populations between January and March 2021. The most recently available NSP for each country, published after 2011, was obtained through publicly accessible online sources or through researcher networks. Data were manually extracted from NSPs using a framework of indicators focusing on trans inclusion in these five major sections of NSPs: (1) narratives; (2) epidemiological data; (3) monitoring and evaluation (M&E) indicators and targets; (4) activities; and (5) budgets. RESULTS AND DISCUSSION: Within all reviewed NSPs, 65.0% (39/60) mentioned trans people in at least one of the five key sections but only 8.3% (5/60) included trans people in all five key sections. Trans people were more commonly mentioned in the background/narratives of NSPs (61.7%, 37/60) but less commonly included NSP activities (38.3%, 23/60), in M&E indicators and targets (23.7%, 14/60), in epidemiological data (20.0% 12/60), and in NSP budgets (13.3%, 8/60). Countries in the Asia and Pacific region most frequently included trans people in all five key sections (38%, 5/13), while no countries in Eastern and Southern Africa included trans people in all NSP sections. CONCLUSIONS: This analysis finds substantial gaps in the inclusion of trans populations in NSPs globally. Results highlight the pressing need for states, technical partners, and international funders to engage with trans communities to improve trans‐inclusion in all key sections of NSPs. Trans inclusion in NSPs is an essential step towards reaching the populations most at risk of HIV and ultimately achieving country‐level epidemic control. John Wiley and Sons Inc. 2021-11-11 /pmc/articles/PMC8582022/ /pubmed/34761871 http://dx.doi.org/10.1002/jia2.25837 Text en © 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Sherwood, Jennifer
Lankiewicz, Elise
Castellanos, Erika
O'Connor, Naomhán
Theron, Liesl
Restar, Arjee
Assessing inclusion of trans people in HIV national strategic plans: a review of 60 high HIV prevalence countries
title Assessing inclusion of trans people in HIV national strategic plans: a review of 60 high HIV prevalence countries
title_full Assessing inclusion of trans people in HIV national strategic plans: a review of 60 high HIV prevalence countries
title_fullStr Assessing inclusion of trans people in HIV national strategic plans: a review of 60 high HIV prevalence countries
title_full_unstemmed Assessing inclusion of trans people in HIV national strategic plans: a review of 60 high HIV prevalence countries
title_short Assessing inclusion of trans people in HIV national strategic plans: a review of 60 high HIV prevalence countries
title_sort assessing inclusion of trans people in hiv national strategic plans: a review of 60 high hiv prevalence countries
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582022/
https://www.ncbi.nlm.nih.gov/pubmed/34761871
http://dx.doi.org/10.1002/jia2.25837
work_keys_str_mv AT sherwoodjennifer assessinginclusionoftranspeopleinhivnationalstrategicplansareviewof60highhivprevalencecountries
AT lankiewiczelise assessinginclusionoftranspeopleinhivnationalstrategicplansareviewof60highhivprevalencecountries
AT castellanoserika assessinginclusionoftranspeopleinhivnationalstrategicplansareviewof60highhivprevalencecountries
AT oconnornaomhan assessinginclusionoftranspeopleinhivnationalstrategicplansareviewof60highhivprevalencecountries
AT theronliesl assessinginclusionoftranspeopleinhivnationalstrategicplansareviewof60highhivprevalencecountries
AT restararjee assessinginclusionoftranspeopleinhivnationalstrategicplansareviewof60highhivprevalencecountries